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Abstract
Background
The lack of an effective diagnostic tool for Carrion’s disease leads to misdiagnosis, wrong
treatments and perpetuation of asymptomatic carriers living in endemic areas. Conventional
PCR approaches have been reported as a diagnostic technique. However, the detection
limit of these techniques is not clear as well as if its usefulness in low bacteriemia cases.
The aim of this study was to evaluate the detection limit of 3 PCR approaches.
Methodology/Principal Findings
We determined the detection limit of 3 different PCR approaches: Bartonella-specific 16S
rRNA, fla and its genes. We also evaluated the viability of dry blood spots to be used as a
sample transport system. Our results show that 16S rRNA PCR is the approach with a low-
est detection limit, 5 CFU/μL, and thus, the best diagnostic PCR tool studied. Dry blood
spots diminish the sensitivity of the assay.
Conclusions/Significance
From the tested PCRs, the 16S rRNA PCR-approach is the best to be used in the direct
blood detection of acute cases of Carrion’s disease. However its use in samples from dry
blood spots results in easier management of transport samples in rural areas, a slight
decrease in the sensitivity was observed. The usefulness to detect by PCR the presence of
low-bacteriemic or asymptomatic carriers is doubtful, showing the need to search for new
more sensible techniques.
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Author Summary
Carrion’s disease is an endemic illness in the Andean valleys of Peru that achieves high
mortality rates in the absence of antibiotic treatment. There are three clinical manifesta-
tions, febrile acute patients, chronic patients as well as asymptomatic carriers. No effective
diagnostic tool exists nowadays leading to misdiagnosis and the perpetuation of the illness.
The objective of this study was to determine the detection limit of three PCR approaches
both from blood samples as well as from filter papers. Furthermore, the specificity was
also accessed. We found that the best PCR approach studied was the amplification of the
16S rRNA from blood samples with a detection limit of 5 CFU/μL, the same when using
dry blood in filter paper, although the obtained bands were not so evident. Present results
highlight the need to develop more sensitive techniques able to be used both in rural areas
and in the detection of asymptomatic carriers.
Introduction
Bartonella bacilliformis is the etiological agent of Carrion’s disease, an overlooked illness with a
lethal febrile stage and a warty phase. Its endemicity is restricted to Peru, Ecuador and Colom-
bia, with some cases having been described in Bolivia and Chile. The transmission is by a
sandfly of the genera Luyzomyia, mostly Lutzomyia verrucarum [1]. The human is the only
reservoir known, and in endemic areas about 40% of asymptomatic carriers have been
described [2]. In addition, Carrion’s disease-like syndromes have been related to two other Bar-
tonella species: Bartonella rochalimae and Bartonella ancashensis [3–5]. Although its relevance
remains uncertain, these species may be an explanation for the Carrion’s disease cases sporadi-
cally reported in distant areas such as Guatemala or Thailand [1]. In fact, B. rochalimae has
been isolated worldwide [6,7].
Although the warty phase is easy to diagnose by the clinic manifestations, the initial febrile
stage as well as asymptomatic carriers, are often misdiagnosed or non-diagnosed leading to
perpetuation of the illness. Correct diagnosis of both acute and asymptomatic carriers is
extremely important and adequate treatment is imperative to save lives. In endemic areas the
diagnosis is usually made by thin blood smear and/or by clinical data. Despite having a specific-
ity of microscopy of 96%, a low sensitivity of 36% has been described [8]. Moreover, other dis-
eases such as malaria, dengue or tuberculosis that are also present, should be taken into
account, since the first symptoms are common and may lead to misdiagnosis and erroneous
treatments. All these factors are of enormous relevance since the mortality rates of Carrion’s
disease are of 40–85% without treatment [9]. Furthermore, even despite receiving correct treat-
ment the mortality rate is of 10% [10]. A more reliable method is blood culture but this is cum-
bersome, time-consuming and contaminations have been described in the 7–20% of the
cultures [11]. Serologic tests have also been described and show a higher specificity of about
85% for both IgM ELISA and indirect fluorescence antibody test, but are difficult for routine
practice [1]. Molecular diagnosis by PCR is probably the easiest way to achieve a more accurate
diagnosis in endemic areas, as the equipment required is not as sophisticated or expensive,
may be installed in different Health Regional Centers which may provide diagnosis to more
peripheral patients, and the personnel may be easily trained in technique management. Several
PCR approaches have been described in the literature in the last years [12,13]. However, these
studies do not generally involve a large number of samples and additionally, as occurs with the
remaining diagnostic tools, they are hampered by the lack of a standard case definition. In any
case, PCR approaches have been showed as more effective that optical microscopic [12], being
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able to diagnostic Carrion's disease patients in acute phase previously classified as negatives by
thin blood smear. Nonetheless, a critical issue is the detection limit of these techniques, raising
doubts about its usefulness in the detection of low-bacteraemia carriers.
Dried blood spot (DBS) is used for the diagnosis of several infectious diseases [14,15], and
has been proposed for use as easy method to transfer blood samples from endemic areas to ref-
erence centers in order to carry out molecular techniques for the diagnosis of Carrion’s disease
[13]. Therefore, since this illness principally affects children in rural areas, DBS may be an easy
solution to both the transportation of samples and for small blood volume collection in the
pediatric setting.
The aim of this study was to evaluate the detection limit of three PCR approaches designed
to detect B. bacilliformis, both in blood and filter papers to test their potential use for transfer-
ring samples from endemic areas to reference centers.
Materials and Methods
Bacterial strain
We used a collection strain of B. bacilliformis from the Institute Pasteur, CIP 57.20 (NCTC
12136). The strain was grown on blood agar (BD, Germany) at 28°C and 5% CO2 until conflu-
ent growth.
Blood samples
To accurately quantify the amount of B. bacilliformis we used flow cytometry from the
Citomics core facility of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDI-
BAPS). For this, one grown agar plate was diluted in appropriate buffer and Perfect-count
microspheres were used. Serial dilutions (106 CFU/mL—10 CFU/mL) were made in whole
blood provided by the blood bank of the Hospital Clinic.
Dry blood spots
One-hundred μL of the above mentioned bacterial serial dilutions were transfered to What-
mann 903 filter papers and let dry at least one week at room temperature to mimic the sample
transfer conditions in a real scenario.
DNA extraction
DNA extraction was done from 100 μL blood and from dry blood spots with the Qiamp DNA
Mini Kit (Qiagen, Germany), according to the manufacturer’s instructions except that the final
elution volume was 100 μL.
PCR amplification
Fragments of Bartonella-specific 16S rRNA, flagellin (fla) genes as well as the variable-inter-
genic region (its) were amplified. The primers used were 5’-CCTTCAGTTMGGCTGGATC-3’
and 5’-GCCYCCTTGCGGTTAGCACA-3’ for 16S rRNA [16], 5’-ATAGAAAGAGCCTGAA
TACC-3’ and 5`-TGATGAAGCATGACAGTAACAC-3’ for flagellin and 5’-AGATGAT
GATCCCAAGCCTTCTGG-3’ [17], and 5’-CTTCTCTTCACAATTTCAAT-3’ [18] for the
amplification of variable-intergenic region. The PCRs were performed in a 25-μL total reaction
volume with 500 nM forward primer, 500 nM reverse primer, 9,75 μL H2O and 5 μL of
DNA following the conditions: 30 seconds at 94°C, 30 seconds at 55°C and 2 minutes at 72°C
for 30 cycles. A 2% agarose gel stained with Sybr Safe was performed, and the results were
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visualized with an ImageQuant LAS4000 transiluminator (GE Healthcare Europe GmbH, Bar-
celona, Spain).
Detection limit
The detection limit was considered as the lowest dilution at which a positive result was obtained
and considering the number of copies of each gene in the B. bacilliformis genome. All the above
mentioned experiments were done in duplicate intra-assay and at two different times.
Specificity
The specificity was tested by doing the same PCR approaches to other member of the Barto-
nella genus both in vitro: Bartonella elizabethae (strain 30455), Bartonella grahamii (strain
50771), Bartonella henselae, Bartonella koehlerae (strain 30773), Bartonella tamiae (Strain
Th307), and Bartonella vinsonii subsp. vinsonii (strain 30453), and in silico for the remaining
25 recognized species plus B. ancashensis. In addition other plate-grown bacteremia microor-
ganisms such as Escherichia coli, Pseudomonas spp., Shigella spp., Klebsiella spp., Haemophilus
spp., Staphylococcus aureus and Streptococcus spp., as well as an intracellular microorganism
such as Ricketsia spp. and Brucella melitensis were also tested.
Results
When DNA was directly extracted from the blood, the detection limit was 5 CFU/μL for both
the Bartonella-specific 16S rRNA and the fla genes. Meanwhile, a limit of 500 CFU/μL was
obtained on amplification of the its region. In the case of DBS, the Bartonella-specific 16S
rRNA PCR approach showed the lowest detection limit, which was also of 5 CFU/μL. Concern-
ing dry blood, despite the detection limit being the same for 16S rRNA and its, the sensitivity
decreased for fla when the detection limit dropped to 500 CFU/μL compared with 5 CFU/μL
obtained directly from blood (Table 1). It was of note that fainter bands were always obtained
with DBS.
Regarding specificity, the 16S rRNA gene amplifies for all Bartonella species (either in vivo
or in silico) but a positive result was also obtained when tested B.melitensis. The its amplifica-
tion assay was specific for Bartonella spp., and no other of the tested microorganisms had a
positive PCR. Moreover, the its scheme might allow to distinguish between different Bartonella
spp. by the different amplified size. The fla gene amplification was also specific for Bartonella
species and differentiates between Bartonella spp. causing Carrion’s disease (B. bacilliformis, B.
rochalimae and B. ancashensis) and the remaining Bartonella causing human disease (Table 2)
once no amplification was obtained or predicted for the last ones.
Discussion
Carrion’s disease is an overlooked and restricted disease that affects the poorest populations
living in remote rural areas, which badly communicated, without equipped laboratories, and
with many other illnesses with a common symptomatology [1]. Thus, correct diagnosis of
Table 1. Detection limit for the 3 PCR approaches studied both for blood samples and dried blood
spots.
Blood samples (CFU/μL) Dried blood spots (CFU/μL)
16S rRNA ﬂa its 16S rRNA ﬂa its
5 5 500 5 500 500
doi:10.1371/journal.pntd.0004529.t001
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Carrion’s disease is essential, particularly since misdiagnosis is frequent [12, 19]. PCR tech-
niques rank among the most rapid techniques to diagnose B. bacilliformis. For this reason, the
determination of the detection limit of these techniques is extremely important. For this study
we have chosen three approaches, the amplification of 16S rRNA, the hypervariable intergenic
transcribed spacer 16S-23S rRNA and the fla gene which codes for the flagelin protein of B.
bacilliformis. The amplification of 16S rRNA has been proposed for Carrion’s disease diagnos-
tic in Peru [12]. All tested Bartonella had an amplified product of 438 bp. Moreover, the in sil-
ico analysis showed that these primers are able to amplify all Bartonella spp. Then, this PCR
approach may be also useful in other environments to detect and identify other Bartonella spp.
either combining with sequencing or RFLP.
Table 2. Amplification sizes in different Bartonella spp. for each of the three PCR approaches in study.
PCR approaches (bp)
Microorganism1 Illness2 16S rRNA its ﬂa
Carrion’s disease involved Bartonella spp.
B. bacilliformis Carrion’s disease 438 545 937
B. rochalimae Carrion’s disease 3 438 696 974
B. ancashensis Carrion’s disease 4 438 590 940
Main Bartonella spp. causing human illness
B. alsatica Endocarditis 438 654 NA
B. clarridgeiae Cat scratch disease 438 692 997
B. elizabethae Endocarditis 438 777 NA
B. henselae Cat scratch disease 438 719 NA
B. grahamii Retinitis 438 715 NA
B. quintana Trench fever, Cat scratch disease 438 619 NA
B. vinsonii subsp. berkhofﬁ Endocarditis 438 727 NA
B. vinsonii subsp. arupensis Bacteremia 438 742 NA
Other Bartonella spp.5
B. bovis 438 525 NA
B. capreoli 438 5646 NA
B. coopersplainsensis 438 701 NA
B. koehlerae 438 677 NA
B. pachyuromydis 438 545 NA
B. queenslandensis 438 715 NA
B. schoenbuchensis 438 527 1008
B. silvatica 438 690 NA
B. taylorii 438 689 NA
1.- The 32 currently recognized Bartonella species (including the three B. vinsonii subsp.) plus B. tamiae were considered.
2.- Only the more relevant pathologies have been referenced here.
3.- Described as one case of Oroya fever-like in a tourist returning from Peru [4].
4.- Described as a cause of Peruvian Wart in children living in an endemic area [3,5].
5.- Most of them isolated from animals, and some sporadically reported from human infections. Indicated are only those microorganisms that have the ﬂa
gene or that the ampliﬁed its product differing 20 bp or less respecting any of Bartonella spp. involved in Carrion’s disease.
6.- Uncertain ampliﬁcation (two gaps close to primer 3’ terminal).
NA: non ampliﬁed or non-predicted ampliﬁcation.
Highlighted in bold when experimental ampliﬁcation of the three PCR approaches in study were performed.
doi:10.1371/journal.pntd.0004529.t002
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The its amplification permits to differentiate between B. bacilliformis and B. ancashensis
from the main pathogenic Bartonella spp [20]. In fact the its region has been used in different
studies of Bartonella spp [7].
Regarding fla, this gene permit to distinguish between the three Bartonella causing Carrion’s
disease: B. bacilliformis (940 pb), B. rochalimae (974 bp) and B. ancashensis (937 bp) from the
remaining Bartonella spp. with clinical interest. However, one exception is B. clarridgeiae (997
bp). Additionally, and in silico analysis showed that B. schoenbuchensis will also results in a
positive fragment of 1008 bp.
Our results show that the Bartonella-specific 16S rRNA PCR seems to be the best of the
techniques analyzed to detect the presence of B. bacilliformis in blood samples (5 CFU/μL)
since the lowest detection limit was achieved on comparison with fla and its PCRs. These
results are in accordance with Angkasekwinai et al. [21], who reported a detection limit of 1
and 10 copies/μL in a loop-mediated isothermal amplification when the detection limit was
determined using bacterial genomic DNA alone or in the presence of human plasma respec-
tively. This sensitivity might allow diagnosing the acute cases of Carrion’s disease, in which the
mean percentage of infected RBCs is 61% (ranging from 2 to 100%) [22]. Nonetheless, the con-
comitant use of these PCR approaches will provide information about other Bartonella spp.
infections.
Filter paper may be an alternative for easy transportation of samples from endemic areas to
reference laboratories but the decreasing sensitivity of the results must been taken into account
which may lead to the non-detection of cases with a low bacteremia. Although the same detec-
tion limit was obtained for 16S rRNA PCR both directly from blood and filter papers, the
bands were fainter in the latter. It is true that 1 week delay in the sample processing could affect
the PCR by increasing the detection limit. Nonetheless, in rural settings the transfer of samples
to reference centers is associated with bad communications ways, resulting in some days from
sample collection to molecular determinations.
None of the non-Bartonellamicroorganisms included in the study were positive when its or
fla PCRs were performed. Nonetheless, when Brucella spp. was tested, amplification was
obtained to 16S rRNA PCR. Although this is a limitation, it is need to take into account that a
diagnostic should to be performed both in the adequate clinic context and in parallel with
other diagnostic tools such as differential PCR for Brucella diagnostic when needed [23].
The prevalence of asymptomatic people in endemic areas has already been described by
PCR being 0.5% [1]. However, the number of inhabitants previous exposed increases to around
40% when serologic techniques like ELISA or IFA are performed [1]. It is need to take into
account that B. bacilliformis possess tropism for both erythrocytes and endothelial cells, being
then present a non-blood circulating bacterial. In the chronic illness stage (verrucuous
patients) the sensitivity of the microscopical techniques decreases from the 36% described in
the acute phase to less than 10% [24], highlighting the lower blood bacterial carriage and a pos-
sible transient bacteremia. Those facts might results in false PCR-negative when the technique
is applied in the detection of both verrucous patients and asymptomatic carriers.
It is important to remark that in the last years 2 more sensitive PCR techniques have been
described in the literature: qPCR [13] in which 24.6% of DBS samples are positive, as well as a
loop-mediated isothermal amplification [21] that achieves good results on analysing Lutzomyia
samples. However, qPCR requires the expertise of trained personnel and is more expensive and
difficult to be implemented. Meanwhile the usefulness of loop-mediated isothermal amplifica-
tion remains to be validated to detect the presence of B. bacilliformis in human clinical samples.
Enrichment of the sample before conventional PCR has been proposed to increase the positiv-
ity by 55% when compared with the original blood samples [25]. However, this enrichment
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technique results in a 14-days delay in sample processing thereby making it unaffordable for
diagnostic purposes.
To conclude, here we show that 16S rRNA PCR have low cfu detection limit and should be
used with special attention to test samples from individuals with clinical suspicion of Carrion’s
disease since the applicability to detect healthy carriers is not clear. The use of DBS could facili-
tate the transfer of samples from rural endemic areas to health facilities, despite the possibility
of a small decrease in positivity. It is critical to develop rapid, sensitive and specific techniques
which may be applied in endemic rural areas to avoid misdiagnosis and to facilitate the detec-
tion of asymptomatic carriers and thereby the decrease the number of B. bacilliformis cases.
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